Pharmaceutical Policies in the Biden Agenda
DOI:
https://doi.org/10.57660/dpceonline.2024.2360Abstract
The article provides an analysis of the pharmaceutical policy under the Biden Administration. The focus is on Executive Orders and measures in some key areas such as: lowering prescription drug costs for Americans; strengthening Americans’ access to health coverage; addressing reproductive health and the distribution of abortion pills (a very relevant issue, especially after the US Supreme Court judgment which overruled the leading case Roe versus Wade of 1973).
Keywords: Pharmaceutical policy; US Government; Biden Presidency; Drug costs; Health coverage; Distribution of abortion pill
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 DPCE Online

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC Attribution-NonCommercial-ShareAlike 4.0